• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小剂量阿糖胞苷治疗老年急性髓细胞白血病患者

[Small dose of ARA-C in the treatment of an elderly patient with acute myeloblastic leukemia].

作者信息

Takeyama H, Yano K, Ohoshima K, Satake T, Emi N, Sugihara T, Kawashima K

出版信息

Gan To Kagaku Ryoho. 1983 Nov;10(11):2418-22.

PMID:6579883
Abstract

A 79 year old man with a history of myocardial infarction and cerebral infarction was admitted to our hospital in August, 1982. The hematological examination showed anemia and leukopenia (myeloblast 12%), and bone marrow aspiration confirmed the diagnosis of acute myeloblastic leukemia (FAB, M2). Because his general condition was poor, he was treated with small dose of Ara-C (10 mg/m2/12 hr, subcutaneous injections), obtaining complete remission. In cases of acute myeloblastic leukemia in elderly patients where other intensive treatments are contraindicated, it appears to be useful to employ a method of small dose of Ara-C therapy.

摘要

一名有心肌梗死和脑梗死病史的79岁男性于1982年8月入住我院。血液学检查显示贫血和白细胞减少(原始粒细胞12%),骨髓穿刺确诊为急性髓系白血病(FAB,M2型)。由于他的一般状况较差,给予小剂量阿糖胞苷治疗(10mg/m²/12小时,皮下注射),获得完全缓解。在老年急性髓系白血病患者中,若其他强化治疗禁忌,采用小剂量阿糖胞苷治疗方法似乎是有效的。

相似文献

1
[Small dose of ARA-C in the treatment of an elderly patient with acute myeloblastic leukemia].小剂量阿糖胞苷治疗老年急性髓细胞白血病患者
Gan To Kagaku Ryoho. 1983 Nov;10(11):2418-22.
2
[Long-term survival in an elderly patient with acute myeloblastic leukemia].[一名老年急性髓细胞白血病患者的长期生存]
Gan No Rinsho. 1987 Jun;33(6):698-702.
3
[Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].[奥磷替康治疗老年急性髓系白血病成功病例]
Gan To Kagaku Ryoho. 1994 Mar;21(4):535-8.
4
[Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].[70岁以上急性髓系白血病。小剂量阿糖胞苷治疗的经验]
Sangre (Barc). 1998 Feb;43(1):35-9.
5
[An aged patient with acute myelogenous leukemia complicated with liver cirrhosis: successful treatment with low-dose cytosine arabinoside].
Gan To Kagaku Ryoho. 1989 Jul;16(7):2441-4.
6
[Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia].低剂量阿糖胞苷、阿克拉霉素和重组人粒细胞集落刺激因子(CAG)疗法使严重再生障碍性贫血后发生的伴有7号染色体单体的急性非淋巴细胞白血病达到完全缓解
Rinsho Ketsueki. 1995 Feb;36(2):128-33.
7
[Cytarabine-induced pericarditis].[阿糖胞苷诱导的心包炎]
Rinsho Ketsueki. 1998 Nov;39(11):1115-20.
8
[Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
Schweiz Med Wochenschr. 1984 Dec 1;114(48):1763-6.
9
[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].改良FLAG方案治疗33例复发/难治性白血病的疗效
Ai Zheng. 2003 Dec;22(12):1330-3.
10
A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗急性白血病和难治性淋巴瘤的初步研究:临床反应与药理学
Cancer Res. 1982 Apr;42(4):1587-94.